MACTER · Macter International Limited
Material Information
- Filed
- 25 September 2026 at 12:38 pm
- Category
- Material
- Sentiment
- Good
- Impact
- Medium
AI executive summary
Macter International Limited has announced the successful commercial launch of Hepanox (Enoxaparin Sodium) Pre-Filled Syringe (PFS), a low molecular weight heparin anticoagulant. This new product launch represents a significant milestone in expanding the company's biopharmaceuticals portfolio and strengthens its market presence in the anticoagulant therapeutic segment.
- #hepanox
- #product-launch
- #biopharmaceuticals
- #macter-international
This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.